Characterization of cognitive impairment in adult polyglucosan body disease

Paul Theo Zebhauser, Isabell Cordts, Holger Hengel, Bernhard Haslinger, Paul Lingor, Hasan Orhan Akman, Tobias B. Haack, Marcus Deschauer

Publikation: Beitrag in FachzeitschriftÜbersichtsartikelBegutachtung

7 Zitate (Scopus)

Abstract

Adult polyglucosan body disease (APBD) is a rare but probably underdiagnosed autosomal recessive neurodegenerative disorder due to pathogenic variants in GBE1. The phenotype is characterized by neurogenic bladder dysfunction, spastic paraplegia, and axonal neuropathy. Additionally, cognitive symptoms and dementia have been reported in APBD but have not been studied systematically. Using exome sequencing, we identified two previously unreported bi-allelic missense GBE1 variants in a patient with severe memory impairment along with the typical non-cognitive symptoms. We were able to confirm a reduction of GBE1 activity in blood lymphocytes. To characterize the neuropsychological profile of patients suffering from APBD, we conducted a systematic review of cognitive impairment in this rare disease. Analysis of 24 cases and case series (in total 58 patients) showed that executive deficits and memory impairment are the most common cognitive symptoms in APBD.

OriginalspracheEnglisch
Seiten (von - bis)2854-2861
Seitenumfang8
FachzeitschriftJournal of Neurology
Jahrgang269
Ausgabenummer6
DOIs
PublikationsstatusVeröffentlicht - Juni 2022
Extern publiziertJa

Fingerprint

Untersuchen Sie die Forschungsthemen von „Characterization of cognitive impairment in adult polyglucosan body disease“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren